8-K 1 a05-16485_18k.htm 8-K

 

Securities and Exchange Commission

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

September 14, 2005

 

Prospect Medical Holdings, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

1-32203

 

33-0564370

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

6083 Bristol Parkway, Suite 100

 

 

Culver City, California

 

90230

(Address of principal executive offices)

 

(Zip Code)

 

Registrantís telephone number, including area code: (310) 338-8677

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 3.02.              Recent Sales of Unregistered Securities

 

On September 14, 2005, the Registrant issued the following securities without registration under the Securities Act of 1933 (ěSecurities Actî). Management believes that the securities transaction described below was exempt from the registration requirements of the Securities Act pursuant to Section 4(2) as a transaction not involving any public offering. The number of investors was limited, the investors were accredited and had access to material information about the Registrant, and restrictions were placed on the resale of the securities issued.

 

Title

 

Amount

 

Terms of Exercise

 

Consideration

 

Recipient(s)

Nonqualified options to buy common stock (issued under the Registrantsí 1998 Stock Option Plan)

 

120,000 options

 

Exercisable for five years at an exercise price of $4.86 (the closing stock price on the date of grant)

 

Services rendered for the Registrantís 2005 fiscal year

 

The four outside directors of the Registrant

 

Item 9.01.              Financial Statements and Exhibits

 

(c)           Exhibits

 

The following exhibits are filed with the Form 8-K:

 

Exhibit No.

 

Description

99.1

 

Form of stock option agreement used for incentive stock options granted under the Registrantís 1998 Stock Option Plan, as amended.

 

 

 

99.2

 

Form of stock option agreement used for nonqualified stock options issued under the Registrantís 1998 Stock Option Plan, as amended.

 

The 1998 Stock Option Plan and the First Amendment to the Plan were previously filed as exhibits to the Registrantís Form 10 registration statement on May 27, 2004. The Second Amendment to the Plan was previously filed as an exhibit to the Registrantís Form 10 registration statement on October 21, 2004.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Prospect Medical Holdings, Inc.

 

 

 

 

 

By:

 /s/ Mike Heather

 

 

 

Mike Heather, Chief Financial Officer

 

Dated:  September 20, 2005

 

3